QA: Myovant Sciences Ltd in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001679082_2020_Myovant_Sciences_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001679082, Myovant Sciences Ltd

  xvar xval
0 AssetsCurrent 166,792,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,071,000
3 remainder_Assets 4,114,000
4 LiabilitiesCurrent 71,973,000
5 LiabilitiesNoncurrent 103,040,000
6 remainder_Liabilities -6,370,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 42,219,000
9 ResearchAndDevelopmentExpense 222,607,000
10 remainder_Expenses 9,297,000
11 remainder_Revenues 0
12 remainder_NetIncome 572,000
13 remainder_ComprehensiveNetIncome 483,000
  yvar yval
0 Assets 172,977,000
1 Liabilities 168,643,000
2 Expenses 274,123,000
3 Revenues 0
4 StockholdersEquity 4,334,000
5 NetIncome -273,551,000
6 ComprehensiveNetIncome -273,309,500
7 BaseVar 308,399,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.54
9 EconomicCapitalRatio 1.17

Edgar->Model Mapping

Feature Distribution

Change over Time